| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1A CACNA1B ANO5 TRPV3 KCNK13 ATP13A3 SLC5A8 SLC25A19 SLC16A2 ZDHHC13 SLC2A2 CFTR | 1.51e-06 | 1180 | 39 | 12 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | CACNA1A CACNA1B ANO5 TRPV3 KCNK13 ATP13A3 SLC5A8 SLC25A19 SLC16A2 ZDHHC13 SLC2A2 CFTR | 3.80e-06 | 1289 | 39 | 12 | GO:0005215 |
| GeneOntologyMolecularFunction | corticotropin-releasing hormone receptor activity | 1.11e-05 | 3 | 39 | 2 | GO:0043404 | |
| GeneOntologyMolecularFunction | corticotrophin-releasing factor receptor activity | 1.11e-05 | 3 | 39 | 2 | GO:0015056 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1A CACNA1B ANO5 TRPV3 KCNK13 ATP13A3 SLC5A8 ZDHHC13 CFTR | 1.70e-05 | 793 | 39 | 9 | GO:0015075 |
| GeneOntologyMolecularFunction | amide binding | 2.31e-05 | 299 | 39 | 6 | GO:0033218 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 4.01e-05 | 884 | 39 | 9 | GO:0004930 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 6.26e-05 | 526 | 39 | 7 | GO:0022803 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 8.99e-05 | 758 | 39 | 8 | GO:0015318 | |
| GeneOntologyMolecularFunction | RNA polymerase I general transcription initiation factor activity | 1.33e-04 | 9 | 39 | 2 | GO:0001181 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 1.33e-04 | 9 | 39 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 1.33e-04 | 9 | 39 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 1.68e-04 | 55 | 39 | 3 | GO:0017046 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 1.74e-04 | 431 | 39 | 6 | GO:0004984 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 2.45e-04 | 459 | 39 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 2.52e-04 | 293 | 39 | 5 | GO:0008514 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 2.62e-04 | 465 | 39 | 6 | GO:0046873 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 2.65e-04 | 664 | 39 | 7 | GO:0008324 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 3.33e-04 | 14 | 39 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | gated channel activity | 4.59e-04 | 334 | 39 | 5 | GO:0022836 | |
| GeneOntologyMolecularFunction | channel activity | 5.01e-04 | 525 | 39 | 6 | GO:0015267 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 9.72e-04 | 1353 | 39 | 9 | GO:0004888 | |
| GeneOntologyMolecularFunction | hormone binding | 1.06e-03 | 103 | 39 | 3 | GO:0042562 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.26e-03 | 627 | 39 | 6 | GO:0022890 | |
| GeneOntologyMolecularFunction | calcium channel activity | 2.03e-03 | 129 | 39 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 2.22e-03 | 133 | 39 | 3 | GO:0008528 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 2.24e-03 | 477 | 39 | 5 | GO:0022804 | |
| GeneOntologyMolecularFunction | vitamin transmembrane transporter activity | 2.25e-03 | 36 | 39 | 2 | GO:0090482 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 2.56e-03 | 140 | 39 | 3 | GO:0001653 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 3.17e-03 | 151 | 39 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 3.23e-03 | 152 | 39 | 3 | GO:0022843 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 3.64e-03 | 46 | 39 | 2 | GO:0005245 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 4.13e-03 | 49 | 39 | 2 | GO:0140359 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 4.29e-03 | 50 | 39 | 2 | GO:0099095 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 4.38e-03 | 343 | 39 | 4 | GO:0005261 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 5.35e-03 | 182 | 39 | 3 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 5.51e-03 | 184 | 39 | 3 | GO:0022832 | |
| GeneOntologyMolecularFunction | O-acyltransferase activity | 5.93e-03 | 59 | 39 | 2 | GO:0008374 | |
| GeneOntologyMolecularFunction | general transcription initiation factor activity | 7.81e-03 | 68 | 39 | 2 | GO:0140223 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 1.11e-02 | 238 | 39 | 3 | GO:0016747 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 1.14e-02 | 83 | 39 | 2 | GO:0015101 | |
| GeneOntologyMolecularFunction | chloride channel activity | 1.23e-02 | 86 | 39 | 2 | GO:0005254 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.34e-02 | 90 | 39 | 2 | GO:0008028 | |
| GeneOntologyBiologicalProcess | organic cation transport | 8.65e-06 | 145 | 40 | 5 | GO:0015695 | |
| GeneOntologyBiologicalProcess | calcium ion import | 3.84e-05 | 98 | 40 | 4 | GO:0070509 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1A CACNA1B ANO5 TRPV3 KCNK13 ATP13A3 SLC5A8 ZDHHC13 CRHR1 CRHR2 CFTR | 4.21e-05 | 1374 | 40 | 11 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1A CACNA1B TRPV3 KCNK13 ATP13A3 SLC5A8 ZDHHC13 CRHR1 CRHR2 CFTR | 5.36e-05 | 1157 | 40 | 10 | GO:0006812 |
| GeneOntologyBiologicalProcess | cellular response to corticotropin-releasing hormone stimulus | 5.47e-05 | 6 | 40 | 2 | GO:0071376 | |
| GeneOntologyBiologicalProcess | response to corticotropin-releasing hormone | 5.47e-05 | 6 | 40 | 2 | GO:0043435 | |
| GeneOntologyBiologicalProcess | detection of stimulus | 6.18e-05 | 722 | 40 | 8 | GO:0051606 | |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1A CACNA1B TRPV3 KCNK13 SLC5A8 ZDHHC13 CRHR1 CRHR2 CFTR | 1.00e-04 | 1000 | 40 | 9 | GO:0030001 |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 1.10e-04 | 48 | 40 | 3 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 1.10e-04 | 48 | 40 | 3 | GO:1902656 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 1.14e-04 | 1017 | 40 | 9 | GO:0098660 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | 1.14e-04 | 582 | 40 | 7 | GO:0050906 | |
| GeneOntologyBiologicalProcess | response to pain | 1.32e-04 | 51 | 40 | 3 | GO:0048265 | |
| GeneOntologyBiologicalProcess | negative regulation of epinephrine secretion | 1.63e-04 | 10 | 40 | 2 | GO:0032811 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | 1.71e-04 | 432 | 40 | 6 | GO:0050911 | |
| GeneOntologyBiologicalProcess | regulation of epinephrine secretion | 1.99e-04 | 11 | 40 | 2 | GO:0014060 | |
| GeneOntologyBiologicalProcess | response to amyloid-beta | 2.25e-04 | 61 | 40 | 3 | GO:1904645 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1A CACNA1B ANO5 TRPV3 KCNK13 ATP13A3 ZDHHC13 CRHR1 CFTR | 2.28e-04 | 1115 | 40 | 9 | GO:0034220 |
| GeneOntologyBiologicalProcess | signal release | 2.32e-04 | 653 | 40 | 7 | GO:0023061 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | 2.55e-04 | 465 | 40 | 6 | GO:0007608 | |
| GeneOntologyBiologicalProcess | epinephrine secretion | 2.82e-04 | 13 | 40 | 2 | GO:0048242 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | 3.19e-04 | 485 | 40 | 6 | GO:0050907 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | 3.84e-04 | 942 | 40 | 8 | GO:0098655 | |
| GeneOntologyBiologicalProcess | organic anion transport | 4.39e-04 | 515 | 40 | 6 | GO:0015711 | |
| GeneOntologyBiologicalProcess | peptide hormone secretion | 4.47e-04 | 334 | 40 | 5 | GO:0030072 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | 4.81e-04 | 524 | 40 | 6 | GO:0009593 | |
| GeneOntologyBiologicalProcess | epinephrine transport | 4.90e-04 | 17 | 40 | 2 | GO:0048241 | |
| GeneOntologyBiologicalProcess | peptide secretion | 5.04e-04 | 343 | 40 | 5 | GO:0002790 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase I promoter | 5.50e-04 | 18 | 40 | 2 | GO:0006361 | |
| GeneOntologyBiologicalProcess | peptide transport | 5.89e-04 | 355 | 40 | 5 | GO:0015833 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | 6.03e-04 | 547 | 40 | 6 | GO:0007606 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | 6.12e-04 | 358 | 40 | 5 | GO:0015850 | |
| GeneOntologyBiologicalProcess | regulation of insulin secretion involved in cellular response to glucose stimulus | 7.53e-04 | 92 | 40 | 3 | GO:0061178 | |
| GeneOntologyBiologicalProcess | secretion by cell | 8.59e-04 | 1064 | 40 | 8 | GO:0032940 | |
| GeneOntologyBiologicalProcess | negative regulation of catecholamine secretion | 9.04e-04 | 23 | 40 | 2 | GO:0033604 | |
| GeneOntologyBiologicalProcess | positive regulation of cAMP-mediated signaling | 9.04e-04 | 23 | 40 | 2 | GO:0043950 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 1.00e-03 | 230 | 40 | 4 | GO:0098739 | |
| GeneOntologyBiologicalProcess | insulin secretion involved in cellular response to glucose stimulus | 1.02e-03 | 102 | 40 | 3 | GO:0035773 | |
| GeneOntologyBiologicalProcess | positive regulation of secretion by cell | 1.05e-03 | 404 | 40 | 5 | GO:1903532 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | 1.16e-03 | 1395 | 40 | 9 | GO:0007186 | |
| GeneOntologyBiologicalProcess | hormone secretion | 1.25e-03 | 420 | 40 | 5 | GO:0046879 | |
| GeneOntologyBiologicalProcess | amide transport | 1.25e-03 | 420 | 40 | 5 | GO:0042886 | |
| GeneOntologyBiologicalProcess | hormone transport | 1.42e-03 | 432 | 40 | 5 | GO:0009914 | |
| GeneOntologyBiologicalProcess | export from cell | 1.44e-03 | 1153 | 40 | 8 | GO:0140352 | |
| GeneOntologyBiologicalProcess | exocytosis | 1.45e-03 | 434 | 40 | 5 | GO:0006887 | |
| GeneOntologyBiologicalProcess | positive regulation of secretion | 1.46e-03 | 435 | 40 | 5 | GO:0051047 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 1.75e-03 | 32 | 40 | 2 | GO:0048266 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | 1.79e-03 | 922 | 40 | 7 | GO:0098662 | |
| GeneOntologyBiologicalProcess | regulation of amine transport | 1.82e-03 | 125 | 40 | 3 | GO:0051952 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 1.86e-03 | 33 | 40 | 2 | GO:2000252 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 1.86e-03 | 126 | 40 | 3 | GO:0033555 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 1.91e-03 | 684 | 40 | 6 | GO:0010817 | |
| GeneOntologyBiologicalProcess | chloride transport | 1.95e-03 | 128 | 40 | 3 | GO:0006821 | |
| GeneOntologyBiologicalProcess | secretion | 2.07e-03 | 1221 | 40 | 8 | GO:0046903 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 2.22e-03 | 134 | 40 | 3 | GO:0098661 | |
| GeneOntologyBiologicalProcess | amine transport | 2.37e-03 | 137 | 40 | 3 | GO:0015837 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 2.62e-03 | 142 | 40 | 3 | GO:0099587 | |
| GeneOntologyBiologicalProcess | phenol-containing compound metabolic process | 2.62e-03 | 142 | 40 | 3 | GO:0018958 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 2.62e-03 | 142 | 40 | 3 | GO:0098659 | |
| GeneOntologyBiologicalProcess | regulation of cAMP-mediated signaling | 2.73e-03 | 40 | 40 | 2 | GO:0043949 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | 2.83e-03 | 740 | 40 | 6 | GO:1903530 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 2.90e-03 | 509 | 40 | 5 | GO:0006816 | |
| GeneOntologyBiologicalProcess | negative regulation of amine transport | 3.15e-03 | 43 | 40 | 2 | GO:0051953 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | 5.04e-04 | 1293 | 39 | 9 | GO:0005789 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | 5.21e-04 | 1299 | 39 | 9 | GO:0098827 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | 6.09e-04 | 1327 | 39 | 9 | GO:0042175 | |
| GeneOntologyCellularComponent | apical part of cell | 7.41e-04 | 592 | 39 | 6 | GO:0045177 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 1.19e-03 | 112 | 39 | 3 | GO:0055038 | |
| GeneOntologyCellularComponent | apical plasma membrane | 2.01e-03 | 487 | 39 | 5 | GO:0016324 | |
| Domain | GPCR_2_CRF_rcpt | 1.21e-05 | 3 | 38 | 2 | IPR003051 | |
| Domain | HormR | 1.73e-05 | 25 | 38 | 3 | SM00008 | |
| Domain | HRM | 2.46e-05 | 28 | 38 | 3 | PF02793 | |
| Domain | GPCR_2_secretin-like_CS | 4.45e-05 | 34 | 38 | 3 | IPR017983 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 7.29e-05 | 40 | 38 | 3 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 7.29e-05 | 40 | 38 | 3 | PS50227 | |
| Domain | GPCR_2_extracellular_dom | 7.29e-05 | 40 | 38 | 3 | IPR001879 | |
| Domain | GPHH_dom | 8.41e-05 | 7 | 38 | 2 | IPR031649 | |
| Domain | VDCC_a1su_IQ | 8.41e-05 | 7 | 38 | 2 | IPR014873 | |
| Domain | Ca_chan_IQ | 8.41e-05 | 7 | 38 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 8.41e-05 | 7 | 38 | 2 | PF08763 | |
| Domain | GPHH | 8.41e-05 | 7 | 38 | 2 | PF16905 | |
| Domain | Olfact_rcpt | 1.30e-04 | 393 | 38 | 6 | IPR000725 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 1.43e-04 | 50 | 38 | 3 | PS00650 | |
| Domain | 7tm_2 | 1.43e-04 | 50 | 38 | 3 | PF00002 | |
| Domain | VDCCAlpha1 | 1.80e-04 | 10 | 38 | 2 | IPR002077 | |
| Domain | GPCR_2-like | 2.45e-04 | 60 | 38 | 3 | IPR017981 | |
| Domain | GPCR_2_secretin-like | 2.45e-04 | 60 | 38 | 3 | IPR000832 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 2.58e-04 | 61 | 38 | 3 | PS50261 | |
| Domain | Ion_trans_dom | 1.60e-03 | 114 | 38 | 3 | IPR005821 | |
| Domain | Ion_trans | 1.60e-03 | 114 | 38 | 3 | PF00520 | |
| Domain | 7tm_1 | 2.28e-03 | 677 | 38 | 6 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 2.41e-03 | 685 | 38 | 6 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 2.52e-03 | 691 | 38 | 6 | PS50262 | |
| Domain | GPCR_Rhodpsn | 2.54e-03 | 692 | 38 | 6 | IPR000276 | |
| Domain | Channel_four-helix_dom | 6.00e-03 | 57 | 38 | 2 | IPR027359 | |
| Domain | - | 6.00e-03 | 57 | 38 | 2 | 1.20.120.350 | |
| Domain | GPCR_Rhodpsn_7TM | 1.10e-02 | 670 | 38 | 5 | IPR017452 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 1.89e-05 | 24 | 31 | 3 | MM15992 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 1.89e-05 | 24 | 31 | 3 | M39643 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 1.46e-04 | 47 | 31 | 3 | M19708 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 2.54e-04 | 11 | 31 | 2 | M47958 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 2.54e-04 | 11 | 31 | 2 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 2.54e-04 | 11 | 31 | 2 | M26913 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 3.03e-04 | 60 | 31 | 3 | MM14964 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 5.66e-04 | 681 | 31 | 7 | MM14985 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 8.99e-04 | 736 | 31 | 7 | M27287 | |
| Pathway | WP_TYPE_II_DIABETES_MELLITUS | 1.05e-03 | 22 | 31 | 2 | M39658 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 1.13e-03 | 94 | 31 | 3 | M797 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 1.15e-03 | 23 | 31 | 2 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.36e-03 | 25 | 31 | 2 | M47948 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.59e-03 | 27 | 31 | 2 | M47518 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 1.99e-03 | 417 | 31 | 5 | M4072 | |
| Pubmed | Expression and subcellular localization of CRH and its receptors in human endometrial cancer. | 1.36e-06 | 2 | 41 | 2 | 19433256 | |
| Pubmed | Molecular mechanisms of corticotropin-releasing factor receptor-induced calcium signaling. | 1.36e-06 | 2 | 41 | 2 | 19098121 | |
| Pubmed | Stable respiratory activity requires both P/Q-type and N-type voltage-gated calcium channels. | 1.36e-06 | 2 | 41 | 2 | 23426690 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 20594969 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 37543650 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 22467522 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 31844086 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 17170072 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 14724656 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 23376566 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 17959885 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 18325997 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 17532191 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 12110614 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 23177644 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 32057826 | ||
| Pubmed | Distinct distribution of corticotropin releasing factor receptors in human breast cancer. | 1.36e-06 | 2 | 41 | 2 | 20630588 | |
| Pubmed | Effect of CRHR1 and CRHR2 gene polymorphisms and childhood trauma in suicide attempt. | 1.36e-06 | 2 | 41 | 2 | 30874897 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 24465390 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 38155373 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 15050706 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 23982282 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 21487655 | ||
| Pubmed | Corticotropin-Releasing Hormone Family and Their Receptors in the Cardiovascular System. | 1.36e-06 | 2 | 41 | 2 | 30584229 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 16721033 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 23821771 | ||
| Pubmed | Corticotropin-releasing hormone family of peptides regulates intestinal angiogenesis. | 4.06e-06 | 3 | 41 | 2 | 20206175 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 17463062 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 17517441 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 20032050 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 26907806 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 29466725 | ||
| Pubmed | CRF1 and CRF2 receptors are required for potentiated startle to contextual but not discrete cues. | 4.06e-06 | 3 | 41 | 2 | 19020499 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 15269266 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 14526225 | ||
| Pubmed | Ankyrin-B regulates Cav2.1 and Cav2.2 channel expression and targeting. | 4.06e-06 | 3 | 41 | 2 | 24394417 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 11606463 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 22030710 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 31582756 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 26182893 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 21774994 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 21722209 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 20392192 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 18843268 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 38996073 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 11756502 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 14670995 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 28492284 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 28842924 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 7565810 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 18166336 | ||
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 4.06e-06 | 3 | 41 | 2 | 24523520 | |
| Pubmed | Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord. | 4.06e-06 | 3 | 41 | 2 | 17444496 | |
| Pubmed | Animal models of CRH excess and CRH receptor deficiency display altered adaptations to stress. | 4.06e-06 | 3 | 41 | 2 | 11337086 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 30704133 | ||
| Pubmed | Molecular moieties masking Ca2+-dependent facilitation of voltage-gated Cav2.2 Ca2+ channels. | 4.06e-06 | 3 | 41 | 2 | 29208674 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 12832554 | ||
| Pubmed | Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation. | 4.06e-06 | 3 | 41 | 2 | 26507659 | |
| Pubmed | Lack of interaction between etifoxine and CRF1 and CRF2 receptors in rodents. | 4.06e-06 | 3 | 41 | 2 | 16769145 | |
| Pubmed | Activated CRH receptors inhibit autophagy by repressing conversion of LC3BI to LC3BII. | 4.06e-06 | 3 | 41 | 2 | 30849520 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 30248435 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 19302188 | ||
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 8.12e-06 | 4 | 41 | 2 | 32616470 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 26283199 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 22451915 | ||
| Pubmed | Enhanced pelvic responses to stressors in female CRF-overexpressing mice. | 8.12e-06 | 4 | 41 | 2 | 17194724 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 18591672 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 16734917 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 12784189 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 24776847 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 15728831 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 14736736 | ||
| Pubmed | Labelling of CRF1 and CRF2 receptors using the novel radioligand, [3H]-urocortin. | 8.12e-06 | 4 | 41 | 2 | 9423932 | |
| Pubmed | The MAP1B-LC1/UBE2L3 complex catalyzes degradation of cell surface CaV2.2 channels. | 8.12e-06 | 4 | 41 | 2 | 25483588 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 30214395 | ||
| Pubmed | Structural basis for hormone recognition by the Human CRFR2{alpha} G protein-coupled receptor. | 8.12e-06 | 4 | 41 | 2 | 20966082 | |
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 8.12e-06 | 4 | 41 | 2 | 37141091 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 31253182 | ||
| Pubmed | Distribution and expression of CRF receptor 1 and 2 mRNAs in the CRF over-expressing mouse brain. | 8.12e-06 | 4 | 41 | 2 | 16423327 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 19131402 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 8612563 | ||
| Pubmed | Corticotropin-releasing hormone system in human adipose tissue. | 8.12e-06 | 4 | 41 | 2 | 14764822 | |
| Pubmed | Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors. | 8.12e-06 | 4 | 41 | 2 | 15001778 | |
| Pubmed | G protein-gated inhibitory module of N-type (ca(v)2.2) ca2+ channels. | 8.12e-06 | 4 | 41 | 2 | 15953418 | |
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 8825650 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 20731720 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 16787652 | ||
| Pubmed | A contextual model for axonal sorting into glomeruli in the mouse olfactory system. | 1.35e-05 | 5 | 41 | 2 | 15186781 | |
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 22234467 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 15451373 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 19077175 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 24083959 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 11296258 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 20052275 | ||
| Pubmed | Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein. | 2.03e-05 | 6 | 41 | 2 | 7694569 | |
| Pubmed | An action potential initiation mechanism in distal axons for the control of dopamine release. | 2.03e-05 | 6 | 41 | 2 | 35324301 | |
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 11416224 | ||
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 2.03e-05 | 6 | 41 | 2 | 12827191 | |
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 18384079 | ||
| Pubmed | Association of HPA axis genes with suicidal behaviour in schizophrenia. | 2.03e-05 | 6 | 41 | 2 | 18838498 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 1.43e-04 | 564 | 41 | 5 | chr11p15 | |
| Cytoband | 11p15.4 | 7.68e-04 | 200 | 41 | 3 | 11p15.4 | |
| GeneFamily | Corticotropin releasing hormone receptors | 2.48e-06 | 2 | 29 | 2 | 266 | |
| GeneFamily | Calcium voltage-gated channel subunits | 7.88e-04 | 26 | 29 | 2 | 253 | |
| GeneFamily | Olfactory receptors, family 6 | 3.02e-03 | 51 | 29 | 2 | 153 | |
| GeneFamily | Solute carriers | 3.46e-03 | 395 | 29 | 4 | 752 | |
| GeneFamily | Olfactory receptors, family 10 | 5.00e-03 | 66 | 29 | 2 | 157 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 173 | 41 | 4 | 2226505610af1becc253d0a5550627144ef0ed6b | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.00e-05 | 175 | 41 | 4 | f1394aacc8a94ca555dd19aaed5a18da99c6bf40 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.00e-05 | 175 | 41 | 4 | 7bf1194d93fbe2dbf9d953e0a32b2a6d88251ed1 | |
| ToppCell | Thalamus-Neuronal-Excitatory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.05e-05 | 176 | 41 | 4 | d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.05e-05 | 176 | 41 | 4 | 77c3da2eaa072a6baefb5087fd07ec18c5e271cd | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.19e-05 | 179 | 41 | 4 | bf012825e88626e59cd1deebf67c2cd269ce4829 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-05 | 181 | 41 | 4 | 8fcdab61fad2efd324d2b27c58f5a594f1dc15de | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.44e-05 | 184 | 41 | 4 | 61caaa31975e05c9a6512079c791fed5a9e2d39f | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.44e-05 | 184 | 41 | 4 | 03da0f0f89f1ca5a3ccca1e22972f3129464e68e | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.44e-05 | 184 | 41 | 4 | 9ed2a65a4ca0ebbbb89ace61027522f93369843d | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 190 | 41 | 4 | 36e83995021ba16690f84e2077a9e8baec547d05 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 190 | 41 | 4 | d26be9e1b676f750e716b91ebc3598fac3735612 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.71e-04 | 137 | 41 | 3 | d346086f42d8f04d3fa67fe696834284acdc7080 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-04 | 147 | 41 | 3 | 00619115b9a1ec2b967c2992043b41974ece63c4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.88e-04 | 155 | 41 | 3 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epi_progenitor|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.88e-04 | 155 | 41 | 3 | be575a0096415705dba425002247289ff8f89474 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.18e-04 | 159 | 41 | 3 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-04 | 159 | 41 | 3 | f7803f7b4e0379ae8256ec53110833bedee7db98 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-04 | 159 | 41 | 3 | 6e2d38e78d2ef7803e8bb154b5c788bf62a41045 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.58e-04 | 164 | 41 | 3 | be49af6335f2505065cde2cb9800e4a5516811b1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.83e-04 | 167 | 41 | 3 | 4e613be2b3ba01160b0c0254fce3c4f72220e580 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_MYBPHL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.83e-04 | 167 | 41 | 3 | c7d1e84af1f4d7430858287520ac2cfa36203642 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.83e-04 | 167 | 41 | 3 | 18ad85751bd892309627eefc357eb28ec5a7c300 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.91e-04 | 168 | 41 | 3 | 03c95ad3684caec7a6d581006b237cc5fa230685 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.91e-04 | 168 | 41 | 3 | e20e1936573fdde78426d7a4eb45c458d5c4dbb4 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.91e-04 | 168 | 41 | 3 | 16b517e3159ad6e6d25fd48f7d5f46e77b2b318d | |
| ToppCell | P28-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.91e-04 | 168 | 41 | 3 | 8c8dbdbc7053f34e4ca0c5067af502fbea109fc1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.00e-04 | 169 | 41 | 3 | bddb28a8b9afbe4a68f082e82caf96a6666fc674 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.00e-04 | 169 | 41 | 3 | 5ce46bac8e767feec7ecdc61689de225c49bd3f7 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.00e-04 | 169 | 41 | 3 | 53e863de064d44e1d36e21fb3dbba37ae020f6e9 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epi_progenitor|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.00e-04 | 169 | 41 | 3 | 1a47a4892a5e6a69555f5332308503526e5422a7 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.00e-04 | 169 | 41 | 3 | ec23caecbb0d969307e33e9df8499ddcd1420305 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l12|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.08e-04 | 170 | 41 | 3 | f524b73d65941ebef7671c46df4362a3f15d24fc | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.08e-04 | 170 | 41 | 3 | fefb07a7e308b620f946b9ff2b01e1796446fe38 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 5.08e-04 | 170 | 41 | 3 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.08e-04 | 170 | 41 | 3 | ce2fd2fbbfd152290be0cf8e513f102fdc182b41 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.08e-04 | 170 | 41 | 3 | d0ed3a8a7ad96c05641ec409b0a69c4fb094893c | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-04 | 170 | 41 | 3 | 833b4f44ea1fa673dfc6b43ce45a79fe68ae3b05 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.08e-04 | 170 | 41 | 3 | ab5c6a91c371e4df15b0842828dc55039695ab06 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.08e-04 | 170 | 41 | 3 | 6a98f47f8c2b5b15e09169bd82eff1e6bf76e5a6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_MYBPHL|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.08e-04 | 170 | 41 | 3 | 4aa9e597f6550ac8cac3137a98be58e71efd07d6 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.17e-04 | 171 | 41 | 3 | 3ad4f138d9570500cfb4423a2be16bb7d1cacbf8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-04 | 171 | 41 | 3 | 99176a932569fa1c7e1c01009684f5a65244b96e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_MYBPHL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.17e-04 | 171 | 41 | 3 | 0417fa805ca0acb7e9f6a30bc7b6bdbaba77844d | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-like-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.17e-04 | 171 | 41 | 3 | ca2775a17b5c339c480a963953b6fa2b0731f24d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.26e-04 | 172 | 41 | 3 | 5401ac7739f95fb8681cfb4747ab6e447a3c2ae8 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.26e-04 | 172 | 41 | 3 | b3da7f488d191214d7bb74fbac189fe8c29ee6cd | |
| ToppCell | droplet-Fat-Scat-18m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-04 | 172 | 41 | 3 | 8a4a5ad65eec92ce4fa45c5aa01c28666307455b | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.26e-04 | 172 | 41 | 3 | a9e65201ad9ab4f64251aba2c0bb3d8f9e0193b6 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.26e-04 | 172 | 41 | 3 | 26006967d0c82f7bd9b36a18e97a1b93e856aa67 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.26e-04 | 172 | 41 | 3 | 74dd4a7acb2cf857fed20219e4d7dc1adfbaa398 | |
| ToppCell | P07-Epithelial|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.35e-04 | 173 | 41 | 3 | 8b10087a917b825809d35a2b2b349c73a2782472 | |
| ToppCell | P03-Epithelial-epithelial_progenitor_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.44e-04 | 174 | 41 | 3 | 23c7fdfc73170cfc5cdee5bb7fbee0c8bbbbca07 | |
| ToppCell | droplet-Tongue-Unstain-18m-Myeloid|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-04 | 174 | 41 | 3 | f2eb0199f59e1e2f46da344c05289876bd254fa3 | |
| ToppCell | droplet-Tongue-Unstain-18m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-04 | 174 | 41 | 3 | 9019011eb8d9b7a95804fc11434f0fd42418103a | |
| ToppCell | droplet-Tongue-Unstain-18m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-04 | 174 | 41 | 3 | deafbd0c2523afe09cc42f8c7b33945f3f5c00b4 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 5.53e-04 | 175 | 41 | 3 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | P28-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.53e-04 | 175 | 41 | 3 | 8a4ed775ff973123dbcfe9c809959d11a62450c9 | |
| ToppCell | P03-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.53e-04 | 175 | 41 | 3 | a6d9ca35d3c4b4e3889d0a69b514f63ae630da6b | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 5.53e-04 | 175 | 41 | 3 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial-AT2|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 5.62e-04 | 176 | 41 | 3 | ac76f2cd6c63f30b38b89b58bad2baa4dde8ce3a | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.62e-04 | 176 | 41 | 3 | e74ad0db3b05897edcfabeb11008ede2b9eeb638 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.62e-04 | 176 | 41 | 3 | 76fdf211bce101e83a27d822cb399487bd107027 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.72e-04 | 177 | 41 | 3 | 67cc3a6461db5e0678f96b18224aeb83ad34b0f4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_LINC00507_CTXN3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.72e-04 | 177 | 41 | 3 | 96d639407f79669f3990138793d157b94273581c | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.72e-04 | 177 | 41 | 3 | 71919b5c9bfa87fdd2cd44dfa057b66ea081be5d | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.72e-04 | 177 | 41 | 3 | 092a345cb802f183322aa5542341ba2d96d4f06a | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.72e-04 | 177 | 41 | 3 | 7ac99ff16df94b4e08d361e3d98a7b3af8d6ee3b | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.81e-04 | 178 | 41 | 3 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.00e-04 | 180 | 41 | 3 | 6ac62bf1251978c8c12e715f7b73144fca619794 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-04 | 181 | 41 | 3 | 1037051eb82313c13346617b33f3c4c648181c4d | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.10e-04 | 181 | 41 | 3 | 6730e249cac55ae892cc567d9211615882f3dab4 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.10e-04 | 181 | 41 | 3 | 3462aa1c08fbaf613b6278ab2c7a5a0940bf537d | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.10e-04 | 181 | 41 | 3 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | droplet-Heart-4Chambers-21m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-04 | 181 | 41 | 3 | 3fd16229a63de0971db5d48860c01173d7db518f | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 6.20e-04 | 182 | 41 | 3 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-04 | 182 | 41 | 3 | be8dd52898525ce6632af0adc2801944f3ac10bd | |
| ToppCell | facs-Heart-RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-04 | 182 | 41 | 3 | 8292e8e8474c930ffb88cbab4f6ebdb6f58db645 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-04 | 182 | 41 | 3 | faf0dfa3adc2d2706b6942b5127093ccdc856447 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 6.30e-04 | 183 | 41 | 3 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type | 6.40e-04 | 184 | 41 | 3 | dc71f22583fc54b89b242cbb602f4bbe86f576ec | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.40e-04 | 184 | 41 | 3 | 49705c8fec565b16216bdf48e83e27521f52d99a | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-04 | 185 | 41 | 3 | 0e7351cd6d6e6e8c29573042e168da50ee496cfc | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 6.50e-04 | 185 | 41 | 3 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-04 | 185 | 41 | 3 | 6938ac3cab536cf8a474eba441ce6dcdfcc43b53 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.50e-04 | 185 | 41 | 3 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.50e-04 | 185 | 41 | 3 | 2adb32096aa3473f8d417e5ce9e65264beca9b52 | |
| ToppCell | droplet-Fat-Scat-21m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-04 | 186 | 41 | 3 | de88fafac51049ec1920695844d8ce8057940272 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.60e-04 | 186 | 41 | 3 | 6568358812f0ca4e0161a1a1b29682fbced35c79 | |
| ToppCell | 21-Trachea-Epithelial-Goblet-like_secretory|Trachea / Age, Tissue, Lineage and Cell class | 6.60e-04 | 186 | 41 | 3 | f8cddad28896f0edf10a8645fa49a011b22b120d | |
| ToppCell | droplet-Fat-Scat-21m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-04 | 186 | 41 | 3 | 59710cff3f6f7c318ee2524b44c1a909f312c25e | |
| ToppCell | facs-Lung-18m-Epithelial-alveolar_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.60e-04 | 186 | 41 | 3 | c7214e762b3b48197fdd0b36a50a4de2550a888f | |
| ToppCell | droplet-Fat-Scat-21m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-04 | 186 | 41 | 3 | 7ff73ab8fed5da779ee9c7bd2e14a8363edb7509 | |
| ToppCell | Control-Epithelial-ATII|World / Disease state, Lineage and Cell class | 6.60e-04 | 186 | 41 | 3 | f4b6e401e19a71beddc73d8a1e08359f7c4025cf | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.60e-04 | 186 | 41 | 3 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-04 | 187 | 41 | 3 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | PND03|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.71e-04 | 187 | 41 | 3 | b3fcb36d853adfdea7172c5591de06f027e50af3 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-04 | 188 | 41 | 3 | 842982de2197770f999a70083ed9fca40ac22d79 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-04 | 188 | 41 | 3 | 3dd571bd8e7358b4346dea71f6bf9602dabf583c | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-04 | 188 | 41 | 3 | a0815eaf68eedd6e5ec4af520df80a6ab4eb0864 | |
| Drug | phenylalanyl corticotropin-releasing factor (12-41) | 3.16e-06 | 2 | 41 | 2 | ctd:C113202 | |
| Drug | PNU-107859 | 1.48e-05 | 174 | 41 | 5 | CID004369084 | |
| Drug | AC 110 | 1.89e-05 | 4 | 41 | 2 | CID000022860 | |
| Drug | Crf3 | 1.89e-05 | 4 | 41 | 2 | CID000522687 | |
| Drug | S 8510 | 3.15e-05 | 5 | 41 | 2 | CID005488383 | |
| Drug | 1-EBIO | 4.04e-05 | 37 | 41 | 3 | CID000082320 | |
| Drug | Phloretin | 4.04e-05 | 37 | 41 | 3 | ctd:D010693 | |
| Drug | 8-cyclopentyltheophylline | 4.38e-05 | 38 | 41 | 3 | CID000001917 | |
| Drug | 3,4-dihydroquinazoline | 4.72e-05 | 6 | 41 | 2 | CID000583065 | |
| Drug | methyl nitrate | 4.72e-05 | 6 | 41 | 2 | CID000011724 | |
| Drug | alpha-sialylcholesterol | 4.72e-05 | 6 | 41 | 2 | CID000133976 | |
| Drug | deazapurine | 6.61e-05 | 7 | 41 | 2 | CID000261591 | |
| Drug | 3-cyclohexylpropionate | 6.61e-05 | 7 | 41 | 2 | CID000069702 | |
| Drug | APMPA | 6.61e-05 | 7 | 41 | 2 | CID000512300 | |
| Drug | astressin | 6.61e-05 | 7 | 41 | 2 | ctd:C104416 | |
| Drug | Crf6 | 8.80e-05 | 8 | 41 | 2 | CID005460740 | |
| Drug | astressin B | 1.13e-04 | 9 | 41 | 2 | ctd:C120841 | |
| Drug | SR 48968 | 1.56e-04 | 58 | 41 | 3 | CID000104974 | |
| Drug | 4-aminopiperidine | 1.72e-04 | 11 | 41 | 2 | CID000424361 | |
| Drug | leys | 1.72e-04 | 11 | 41 | 2 | CID000484683 | |
| Drug | IAA-94 | 1.81e-04 | 61 | 41 | 3 | CID000003667 | |
| Drug | AC1NUNCT | 2.06e-04 | 12 | 41 | 2 | CID000093213 | |
| Drug | AC1L2VU3 | 2.06e-04 | 12 | 41 | 2 | CID000129572 | |
| Drug | mibefradil | 2.09e-04 | 64 | 41 | 3 | CID000060662 | |
| Drug | palmatine | 2.44e-04 | 13 | 41 | 2 | CID000019009 | |
| Drug | AC1MIXC3 | 2.44e-04 | 13 | 41 | 2 | CID003081671 | |
| Drug | AC1L2AC7 | 2.61e-04 | 69 | 41 | 3 | CID000068733 | |
| Drug | AC1L1JG6 | 2.84e-04 | 14 | 41 | 2 | CID000005026 | |
| Drug | 1,3-dipropylxanthine | 3.21e-04 | 74 | 41 | 3 | CID000169317 | |
| Drug | butamben | 3.27e-04 | 15 | 41 | 2 | CID000002482 | |
| Drug | P-44 | 3.27e-04 | 15 | 41 | 2 | CID000200876 | |
| Drug | Fedotozina | 3.27e-04 | 15 | 41 | 2 | CID000060764 | |
| Drug | Nitric Oxide | 3.29e-04 | 336 | 41 | 5 | ctd:D009569 | |
| Drug | pentasulfane | 3.74e-04 | 16 | 41 | 2 | CID000448216 | |
| Drug | NBI-27914 | 3.74e-04 | 16 | 41 | 2 | CID000176157 | |
| Drug | Amino nucleoside | 3.74e-04 | 16 | 41 | 2 | CID003000338 | |
| Drug | Verapamil | 3.74e-04 | 16 | 41 | 2 | DB00661 | |
| Drug | DeltaR | 4.23e-04 | 17 | 41 | 2 | CID000028718 | |
| Drug | Phenformin hydrochloride [834-28-6]; Up 200; 16.6uM; HL60; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 2350_UP | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Up 200; 15.6uM; PC3; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 3727_UP | |
| Drug | Haloperidol [52-86-8]; Up 200; 10.6uM; HL60; HG-U133A | 4.45e-04 | 199 | 41 | 4 | 2039_UP | |
| Drug | capsazepine | 4.67e-04 | 84 | 41 | 3 | CID002733484 | |
| Drug | MR 2034 | 4.75e-04 | 18 | 41 | 2 | CID000123980 | |
| Drug | C13932 | 5.07e-04 | 206 | 41 | 4 | CID000168297 | |
| Drug | N6-Me-dAdo | 5.31e-04 | 19 | 41 | 2 | CID000168948 | |
| Drug | pranidipine | 5.31e-04 | 19 | 41 | 2 | CID006436048 | |
| Drug | NIH-3 | 5.31e-04 | 19 | 41 | 2 | CID009822007 | |
| Drug | 5-iodotubercidin | 5.31e-04 | 19 | 41 | 2 | ctd:C034214 | |
| Drug | R1C | 5.89e-04 | 20 | 41 | 2 | CID009961424 | |
| Drug | AC1MBZ1C | 6.26e-04 | 387 | 41 | 5 | CID000003541 | |
| Drug | anilinonaphthalene | 6.50e-04 | 21 | 41 | 2 | CID000008679 | |
| Drug | CGP 52432 | 6.50e-04 | 21 | 41 | 2 | CID000132252 | |
| Drug | CID9572793 | 7.14e-04 | 22 | 41 | 2 | CID009572793 | |
| Drug | N-arachidonoylethanolamine | 7.18e-04 | 226 | 41 | 4 | CID000002185 | |
| Drug | deoxypyridinoline | 7.32e-04 | 98 | 41 | 3 | CID000105071 | |
| Drug | LY320135 | 7.81e-04 | 23 | 41 | 2 | CID005311257 | |
| Drug | Ncz | 7.81e-04 | 23 | 41 | 2 | CID000446415 | |
| Drug | NSC717817 | 7.81e-04 | 23 | 41 | 2 | CID005287845 | |
| Drug | alpha-conotoxin SI | 7.81e-04 | 23 | 41 | 2 | CID000163979 | |
| Drug | droperidol | 7.81e-04 | 23 | 41 | 2 | CID000003168 | |
| Drug | AC1L1D9R | 8.46e-04 | 103 | 41 | 3 | CID000002254 | |
| Drug | pD 8 | 8.52e-04 | 24 | 41 | 2 | CID000656948 | |
| Drug | PCMBS | 8.94e-04 | 105 | 41 | 3 | CID000011136 | |
| Drug | levodopa/carbidopa | 1.00e-03 | 26 | 41 | 2 | CID000104778 | |
| Drug | Shu 9119 | 1.00e-03 | 26 | 41 | 2 | CID006440621 | |
| Drug | mAHP | 1.08e-03 | 27 | 41 | 2 | CID000220531 | |
| Drug | Immucillin-G | 1.08e-03 | 27 | 41 | 2 | CID000001334 | |
| Drug | eniluracil | 1.08e-03 | 27 | 41 | 2 | CID000043157 | |
| Drug | sodium silicate | 1.16e-03 | 28 | 41 | 2 | CID000023266 | |
| Drug | Virginiamycin S1 | 1.16e-03 | 28 | 41 | 2 | CID000122731 | |
| Drug | AC1NBU2S | 1.22e-03 | 117 | 41 | 3 | CID004473765 | |
| Drug | homophenylalanine | 1.33e-03 | 30 | 41 | 2 | CID000102530 | |
| Drug | InsS6 | 1.33e-03 | 30 | 41 | 2 | CID000065302 | |
| Drug | amlodipine | 1.51e-03 | 126 | 41 | 3 | CID000002162 | |
| Drug | CNQX | 1.51e-03 | 126 | 41 | 3 | CID000002821 | |
| Drug | 3-aminopropylphosphinic acid | 1.52e-03 | 32 | 41 | 2 | CID006335948 | |
| Drug | polyethylenimine | 1.58e-03 | 128 | 41 | 3 | CID000009033 | |
| Drug | A61603 | 1.61e-03 | 33 | 41 | 2 | CID004038180 | |
| Drug | CNS 1145 | 1.61e-03 | 33 | 41 | 2 | CID000190902 | |
| Drug | IHC-64 | 1.61e-03 | 33 | 41 | 2 | CID000162753 | |
| Drug | 6,7-dinitroquinoxaline | 1.61e-03 | 33 | 41 | 2 | CID002724608 | |
| Drug | Aliquat 336 | 1.71e-03 | 34 | 41 | 2 | CID000021218 | |
| Drug | fluspirilene | 1.71e-03 | 34 | 41 | 2 | CID000003396 | |
| Drug | Barium permanganate | 1.77e-03 | 133 | 41 | 3 | CID000024587 | |
| Disease | functional colonic disease (biomarker_via_orthology) | 5.37e-06 | 3 | 40 | 2 | DOID:3877 (biomarker_via_orthology) | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 5.37e-06 | 3 | 40 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 1.07e-05 | 4 | 40 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | migraine with aura (is_implicated_in) | 2.68e-05 | 6 | 40 | 2 | DOID:10024 (is_implicated_in) | |
| Disease | hereditary ataxia (implicated_via_orthology) | 3.75e-05 | 7 | 40 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | irritable bowel syndrome (biomarker_via_orthology) | 4.99e-05 | 8 | 40 | 2 | DOID:9778 (biomarker_via_orthology) | |
| Disease | asthma (is_implicated_in) | 6.07e-05 | 157 | 40 | 4 | DOID:2841 (is_implicated_in) | |
| Disease | Anorexia | 2.70e-04 | 18 | 40 | 2 | C0003123 | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 3.35e-04 | 20 | 40 | 2 | DOID:2921 (biomarker_via_orthology) | |
| Disease | Coronary heart disease | 4.85e-04 | 24 | 40 | 2 | C0010068 | |
| Disease | Anhedonia | 4.85e-04 | 24 | 40 | 2 | C0178417 | |
| Disease | Dwarfism | 5.27e-04 | 25 | 40 | 2 | C0013336 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 1.26e-03 | 157 | 40 | 3 | DOID:14330 (implicated_via_orthology) | |
| Disease | Anxiety Disorders | 1.64e-03 | 44 | 40 | 2 | C0003469 | |
| Disease | Anxiety neurosis (finding) | 1.64e-03 | 44 | 40 | 2 | C1279420 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FNYYLIFFFGSDFEN | 131 | P20292 | |
| TFFAFCYPFSYSDCQ | 151 | Q8NDL9 | |
| CGNEFAYFYFVSFIF | 1781 | O00555 | |
| FLFQFVNFYSSCFYV | 561 | Q75V66 | |
| VNFYSSCFYVAFFKG | 566 | Q75V66 | |
| YVRYFNSSAFFFSGF | 301 | P13569 | |
| CYKNYFFVFSVIFLY | 1101 | Q9H7F0 | |
| YFVQNTDFDFFSYAG | 226 | Q6P575 | |
| VNYFFYGETVTDYFF | 136 | O95674 | |
| SDFAYFYFVSFIFLC | 1681 | Q00975 | |
| NCFGDYHVAFYFAGV | 471 | P36021 | |
| YYGCALQFYFFCTFA | 96 | Q13606 | |
| NNSEFYGFSEFFYCT | 411 | Q9NQZ7 | |
| FEEFGFFYFFTGSSQ | 441 | P08254 | |
| YDSFRYQGLAFSVFF | 66 | Q8N5G2 | |
| YVFFQFYLLAFFFIF | 251 | A6NMU1 | |
| YIADFCGPYVFFLFA | 456 | P11168 | |
| FLQSFQGFFVSVFYC | 346 | Q13324 | |
| QGFFVSVFYCFFNGE | 351 | Q13324 | |
| GWSYFDSLYFCFVAF | 221 | Q9HB14 | |
| TQMYFFFFFGVAECF | 86 | Q9H208 | |
| FAACITQFYFYFFLG | 96 | Q8NH40 | |
| TQFYFYFFLGASEFL | 101 | Q8NH40 | |
| FSDFLFAFQIQFYYS | 136 | Q9H6J7 | |
| RIFGFYCCVFYGQSF | 246 | Q58HT5 | |
| ESFQGFFVSVFYCFL | 381 | P34998 | |
| LDFAYHFTVFVFYFG | 101 | Q969L2 | |
| QMYFFFFFGVAECFL | 101 | Q9H207 | |
| VIGFIVFCFLCYFFF | 576 | Q86T96 | |
| FCFTSNFNGRFYYLI | 251 | P10915 | |
| FFFFGVKVHCQYETY | 11 | Q99983 | |
| FYSACQAVFYTFVFR | 456 | Q9NYV6 | |
| KFAQVFGCFFYVYYI | 326 | P35610 | |
| FGCFFYVYYIFERLC | 331 | P35610 | |
| FGAIFSIFAFTYFFV | 81 | Q8N695 | |
| FRFFVFFFVYICQFA | 216 | O15126 | |
| ISFAGCITQCYFYFF | 91 | Q8NGC5 | |
| FYFSFIFSIVAFLYF | 376 | Q8IUH4 | |
| FYSACQAVFYTFVFR | 81 | Q2M238 | |
| FFTFQLLFYFVSYWF | 16 | Q96MV1 | |
| NFVAAYDIGLFAYFF | 286 | Q9P283 | |
| FNSFQGFFVSIIYCY | 401 | P49190 | |
| FFLSFCFYFFYNITL | 441 | Q8NET8 | |
| FGNCFALAYFPYFIT | 6 | Q9BVK8 | |
| TGFMFFSYEFFCNVF | 296 | Q9HC21 |